MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BCYC made $72,586K in revenue. -$222,584K in net income. Net profit margin of -306.65%.

Income Overview

Revenue
$72,586K
Net Income
-$222,584K
Net Profit Margin
-306.65%
EPS
-$3.16
Unit: Thousand (K) dollars
Revenue Breakdown
    • Novartis Collaboration Agreement
    • Genentech
    • Bayer
    • Ionis Collaboration Agreement

Income Statement
2025-12-31
Collaboration revenue
72,586
Research and development
240,283
General and administrative
79,368
Total operating expenses
319,651
Loss from operations
-247,065
Interest and other income
28,463
Interest expense
206
Total other income, net
28,257
Net loss before income tax provision
-218,808
Provision for (benefit from) income taxes
152
Net loss
-218,960
Foreign currency translation adjustment
-3,624
Total comprehensive loss
-222,584
Basic EPS
-3.16
Diluted EPS
-3.16
Basic Average Shares
69,279,838
Diluted Average Shares
69,279,838
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$222,584K Net loss-$218,960K Foreign currencytranslation adjustment-$3,624K Interest and other income$28,463K Net loss beforeincome tax provision-$218,808K Provision for (benefitfrom) income taxes$152K Total other income,net$28,257K Novartis CollaborationAgreement$46,985K Genentech$14,681K Bayer$8,920K Ionis CollaborationAgreement$2,000K Interest expense$206K Loss from operations-$247,065K Collaboration revenue$72,586K Total operatingexpenses$319,651K Research and development$240,283K General andadministrative$79,368K

BICYCLE THERAPEUTICS PLC (BCYC)

BICYCLE THERAPEUTICS PLC (BCYC)